Cargando…
Leukemia inhibitory factor is involved in the pathogenesis of NSCLC through activation of the STAT3 signaling pathway
Leukemia inhibitory factor (LIF) is a tumor promoter in several cancer types. However, the role of LIF in non-small cell lung cancer (NSCLC) remains to be explored. The present study explored the hypothesis that LIF is important for NSCLC development by measuring LIF expression and its downstream si...
Autores principales: | Wang, Huaying, Si, Sai'nv, Jiang, Mingjun, Chen, Liping, Huang, Kefeng, Yu, Wanjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8299032/ https://www.ncbi.nlm.nih.gov/pubmed/34386085 http://dx.doi.org/10.3892/ol.2021.12924 |
Ejemplares similares
-
Is the JAK-STAT Signaling Pathway Involved in the Pathogenesis of Depression?
por: Gałecka, Małgorzata, et al.
Publicado: (2022) -
Leukemia inhibitory factor promotes EMT through STAT3-dependent miR-21 induction
por: Yue, Xuetian, et al.
Publicado: (2015) -
New insights into Chlamydia pathogenesis: Role of leukemia inhibitory factor
por: Wang, Jun, et al.
Publicado: (2022) -
Lipin1 Is Involved in the Pathogenesis of Diabetic Encephalopathy through the PKD/Limk/Cofilin Signaling Pathway
por: Xie, Min, et al.
Publicado: (2020) -
Requirement of Leukemia Inhibitory Factor or Epidermal Growth Factor for Pre-Implantation Embryogenesis via JAK/STAT3 Signaling Pathways
por: Cheng, En-Hui, et al.
Publicado: (2016)